Intrinsic4D Inc.

January 06, 2016 16:31 ET

Intrinsic4D Engages The Howard Group for Strategic Investor Communications

TORONTO, ONTARIO--(Marketwired - Jan. 6, 2015) - Intrinsic4D Inc. ("Intrinsic4D") (TSX VENTURE:IFD) is pleased to announce that it has engaged The Howard Group Inc. ("The Howard Group") as its strategic investor communications advisor. The Howard Group will direct both traditional and online initiatives targeting the investment community and the investing public.

The agreement has a term of one year effective January 1, 2016. The remuneration payable to The Howard Group will be $7,500 per month plus GST and Intrinsic4D has granted The Howard Group 300,000 stock options, which shall be exercisable at $0.45 per share, and expire on December 31, 2018. The agreement together with the granting of the stock options is subject to the approval of the TSX Venture Exchange.

Grant Howard, President of The Howard Group noted that, "Intrinsic4D is an extremely interesting Software as a Service (SaaS) opportunity, which only began trading on the TSX Venture Exchange this past summer. We expect interest will grow quickly amongst the investing public and investment community for this revenue generating software technology company. It has patented and FDA approved software technologies that convert a standard CT or MRI scan into 3D. This leads to expedited settlement of personal injury claims and importantly, reducing or eliminating the need for litigation. In addition, Intrinsic4D is now extending the technology's capabilities into cardiac assessment."

Since 1988, The Howard Group has provided comprehensive investor outreach and capital markets programs, business development solutions, strategic planning and financing services to public companies. The Howard Group is associated with the Insight Limited Partnership II, which invests in micro and small cap companies.

In addition, The Howard Group will be providing an ongoing commentary on Intrinsic4D's activities through its "Insight" blog. Interested parties are encouraged to subscribe to the commentary feed:

About Intrinsic4D Inc.

Intrinsic4D through its Authentic brand, is the developer of the patented and FDA-cleared transformative software-as-a-service medical platform servicing the medical-legal industry and through its patented and disruptive Stenosis Severity Mapping (SSM) Cardio solution aims to reduce the $13 billion of unnecessary cardiac catheterizations performed annually, attributed to false positive reads of diagnostic tests for evaluating coronary artery disease.

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws. Forward-looking information may relate to Intrinsic4D's future outlook and anticipated events or results. Particularly, statements regarding future results, performance, achievements and prospects or opportunities for Intrinsic4D are forward looking statements. Some of the specific forward looking statements in this press release include, but are not limited to, statements with respect to the software leading to expedited settlement of personal injury claims and reducing or eliminating the need for litigation, and TSX Venture Exchange approval of the agreement and stock options for The Howard Group. Although the forward-looking statements contained in this press release are based upon assumptions that management of Intrinsic4D believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond Intrinsic4D's control, which may cause actual results to differ materially from those expressed or implied by such forward-looking statements. The forward-looking statements made in this press release relate only to events or information as of the date hereof. Except as required by applicable law, Intrinsic4D undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information